EXECUTIVE SEPARATION AGREEMENTExecutive Separation Agreement • August 16th, 2023 • Aceragen, Inc. • Biological products, (no disgnostic substances) • Delaware
This Executive Separation Agreement (this “Agreement”), is entered into as of August 15, 2023 (the “Execution Date”), by and between John Taylor (“you”) and Aceragen, Inc., a Delaware corporation (together with its wholly owned subsidiaries and affiliates, the “Company”).
GENERAL ASSIGNMENT FOR THE BENEFIT OF CREDITORSGeneral Assignment for the Benefit of Creditors • August 16th, 2023 • Aceragen, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS GENERAL ASSIGNMENT FOR THE BENEFIT OF CREDITORS (the “General Assignment”) is made this 16th day of August, 2023 (the “Effective Date”), by and between Aceragen, Inc., a Delaware corporation located at 505 Eagleview Boulevard, Exton, PA 19341, Federal Tax Identification Number 04-3072298, hereinafter referred to as “Assignor” and ACG (ABC), LLC, a Delaware limited liability company, with offices in care of Rock Creek Advisors, LLC (“Rock Creek”), 1738 Belmar Blvd., Belmar, New Jersey 07719, Federal Tax Identification Number 93-2643891, hereinafter referred to as “Assignee.”
